International Clinical Trial: MEGA-dose aSCORbatE for Sepsis 2.0 (MEGASCORES 2.0) - a phase Ib multi-centre open-label randomised controlled trial to determine the feasibility and effectiveness of mega-dose sodium ascorbate in adults with septic shock

Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001401448) titled 'MEGA-dose aSCORbatE for Sepsis 2.0 (MEGASCORES 2.0) - a phase Ib multi-centre open-label randomised controlled trial to determine the feasibility and effectiveness of mega-dose sodium ascorbate in adults with septic shock' on Dec. 15.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Parallel Type of endpoint: Safety/efficacy

Primary Sponsor: The Florey Institute

Condition: Sepsis Sepsis Infection - Other infectious diseases

Intervention: 9% sodium ascorbate will be presented in 5% dextrose and administered in...